← Leaderboards
Elias K. Halvas
University Of Pittsburgh At Pittsburgh
$3,617,103
Attributed
$3,617,103
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $750.2K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,617,103 · 1
By mechanism
R01$3,617,103 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Michael S. Diamond$85,358,908
- Matthew S Freiberg$20,071,860
- Binfeng Lu$6,521,286
- Joseph C. Glorioso$19,383,290
- Charles R Rinaldo$100,535,685
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesHiv InfectionsAntiretroviral TherapyAutologousHiv-1BloodCase StudyCd4 Positive T LymphocytesCd8-Positive T-LymphocytesCell KillingCellsAntibody-Dependent Cell CytotoxicityClone CellsCollaborationsCytotoxicCytotoxic T-LymphocytesDesignEpitopesEvaluationFailureGene SilencingGenetic TranscriptionGenome SequencingHiv Seropositivity
Grant awards (5)
Understanding Immune Evasion by HIV-1 Repliclones$699,041
R01 · FY2025 · AI · contact PI
Understanding Immune Evasion by HIV-1 Repliclones$707,074
R01 · FY2024 · AI · contact PI
Understanding Immune Evasion by HIV-1 Repliclones$726,797
R01 · FY2023 · AI · contact PI
Understanding Immune Evasion by HIV-1 Repliclones$733,948
R01 · FY2022 · AI · contact PI
Understanding Immune Evasion by HIV-1 Repliclones$750,243
R01 · FY2021 · AI · contact PI